Skip to main content

Table 1 Epidemiological and clinical characteristic of the MS patients and the healthy donors

From: Suppression of neuroinflammation by an allosteric agonist and positive allosteric modulator of the α7 nicotinic acetylcholine receptor GAT107

  Healthy donors MS patients
n 24 32
Female/male 19/5 23/9
Age (mean ± SE) 36.4 ± 3.2 40.1 ± 2.5
Disease duration (mean ± SE) -- 7.4 ± 1.1
EDSS (mean ± SE) -- 2.2 ± 0.3